共 71 条
[1]
Zalewski B(2004)Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features World J Gastroenterol 10 583-53
[2]
Lage H(2008)An overview of cancer multidrug resistance: a still unsolved problem Cell Mol Life Sci 65 3145-1569
[3]
Sastre RL(2004)Preparation and characterization of 5-fluorouracil-loaded poly (ϵ-caprolactone) microspheres for drug administration Drug Dev Res 63 41-2911
[4]
Zhang N(2008)5-Fluorouracil: mechanisms of resistance and reversal strategies Molecules 13 1551-338
[5]
Ramanathan RK(2003)Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal cancer J Clin Oncol 21 2904-479
[6]
Haggar FA(2009)Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors Clin Colon Rectal Surg 22 191-12
[7]
Boushey RP(2003)5-Fluorouracil—mechanisms of action and clinical strategies Nat Rev Cancer 3 330-592
[8]
Longey D(2019)pH-sensitive ZnO/carboxymethyl cellulose/chitosan bio-nanocomposite beads for colon-specific release of 5-fluorouracil Int J Biol Macromol 128 468-704
[9]
Harkin D(2017)P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting Sci Rep 7 1-959
[10]
Jonson PG(2006)Drug penetration in solid tumours Nat Rev Cancer 6 583-171